Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts

Annals of the Rheumatic Diseases

Volumn 67, Issue 5, 2008, Pages 631-637

  Garcia S ^a   Bodano A ^a   Pablos, J L ^b   Gomez Reino J J ^a   Conde, C ^a  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDRO 5 [4 1(1 PIPERIDINYL)BUTHOXY] 1(2H) ISOQUINOLINONA; 4 AMINO 1,8 NAPHTHALIMIDA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

1-NAPHTHYLAMINE; APOPTOSIS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; DEPRESSION, CHEMICAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; ISOQUINOLINES; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHALIMIDES; NF-KAPPA B; PIPERIDINES; POLY(ADP-RIBOSE) POLYMERASES; QUINOLONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTORS;

EID: 42449115654     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077040     Document Type: Article

References (36)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
2. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
3. Sweeney SE, Firestein GS. Signal transduction in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:231-7.
4. Inoue T, Boyle DL, Corr M, Deepa Hammaker, Roger J Davis, Richard A Flavell, et al. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc Natl Acad Sci USA 2006;103:5484-9.
5. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WV, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3 kinase/Akt-dependent pathways. Arthritis Res Ther 2004;6:R120-8.
6. de Murcia G, Ménissier-de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994;19:172-6.
7. Shall S, de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutation Res 2000;460:1- 15.
8. Oliver FJ, Ménissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J 1999;18:4446-54.
9. Burkat V, Wang ZQ, Radons J, Heller B. Herceg Z, Stingl L, et al. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin. Nat Med 1999;5:314-19.
10. Zingarelli B, Szabo C, Salzman AL. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 1999;116:335-45.
11. Mabley JG, Jagtap P, Perretti M, Gelting SJ, Salzman AL, Virag L, et al. Anti-inflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm Res 2001;50:561-9.
12. Mustapha O, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, et al. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. J Immunol 2006;177:6489-96.
13. Hassa PO, Hottiger MO. A role of poly(ADP-ribose) polymerase in NF-kB transcriptional activation. J Biol Chem 1999;380:953-9.
14. Ha HC, Hester LD, Snyder SH. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 2002;99:3270-5.
15. Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003;170:2113-20.
16. Garcia S, Bodaño A, Gonzalez A, Forteza J, Gomez-Reino JJ, Conde C. Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther 2006;8:R14-22.
17. Miesel R, Kurpisz M, Kroger H. Modulation of inflammatory arthritis by inhibition of poly(ADP-ribose) polymerase. Inflammation 1995;19:379-87.
18. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998;95:3867-72.
19. Mazzon E, Serraino I, Li JH, Dugo L, Caputi AP, Zhang J, et al. GPI 6150 a poly(ADP-ribose) polymerase inhibitor exhibits an anti-inflammatory effect in rat models of inflammation. Eur J Pharmacol 2001;0415:85-94.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Artritis Rheum 1987;31:315-24.
21. Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006;2:619-26.
22. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
23. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
24. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S, et al. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993;69:83-91.
25. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998;89:44-53.
26. Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk MH. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol 2000;27:2761-8.
27. Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998;41:110-21.
28. Youn J, Kim HY, Park JH, Hwang SH, Lee SY, Cho CS. Regulation of TNF-α-mediated hyperplasia through TNF receptors, TRAFs, and NFκB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 2002;83:85-93.
29. Derek L, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003;48:103-9.
30. Okazaki Y, Sawada T, Nagatani K, Komagata Y, Inoue T, Muto S, et al. Effect of nuclear factor-kB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol 2005;32:1440-7.
31. Zingarelli B, Hake PW, Burroughs TJ, Piraino G, O'Connor M, Denenberg A. Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology 2004;113:509-17.
32. Zingarelli B, Hake PW, O'Connor M, Denenberg A, Kong S, Aronow BJ. Absence of poly(ADP-ribose) polymerase-1 alters nuclear factor-κB activation and gene expression of apoptosis regulators after reperfusion injury. Mol Med 2003;9:143-53.
33. Martin-Oliva D, Aguilar-Quesada R, O'Valle F, Munoz-Gamez JA, Martinez-Romero R, Garcia del Moral R, et al. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 2006;66:5744-56.
34. Xu Y, Huang S, Liu ZG, Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 2006;281:8788-95.
35. Uehara N, Miki K, Tsukamoto R, Matsuoka Y, Tsubura A. Nicotinamide blocks N- methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly(ADP-ribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Exp Eye Res 2006;82:488-95.
36. Carrillo A, Monreal Y, Ramirez P, Marin L, Parrilla P, Yelamos J. Transcription regulation of TNF-?-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acid Res 2004;32:757-66.